Prothena reported $1.52M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Akebia Therapeutics AKBA:US USD 48.96M 77.8M
ALKERMES ALKS:US USD 252.36M 23.86M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Amgen AMGN:US USD 6.65B 58M
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bluebird Bio BLUE:US USD 71K 1.45M
Exelixis EXEL:US USD 411.74M 7.69M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
IONIS PHARMACEUT IONS:US USD 159.77M 25.98M
Macrogenics MGNX:US USD 41.73M 15.73M
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Prothena PRTA:US USD 1.52M 205K
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
Xoma XOMA:US USD 451K 532K
YTE INCY:US USD 823.3M 88.09M